# Endometriosis

Type: Company

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/endometriosis
Canonical HTML page: https://getbiobrief.com/entity/endometriosis

## Recent coverage (1 stories)

### Endometriosis tests advance abroad while U.S. lags for 1 in 10 women
2026-09-06 00:07:10 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

Non-invasive endometriosis tests advancing abroad highlight a diagnostic market serving 1 in 10 women, but U.S. availability lags and experts warn current tools are not complete solutions. For biotech and pharma, the opportunity lies in validating biomarkers or imaging that can beat surgical confirmation on sensitivity and cost. Regulatory clearance and clinical trial evidence, not patient demand, remain the gating factors.
Full story: https://getbiobrief.com/story/endometriosis-noninvasive-tests-us-regulatory-gap

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.